Antibodies against carbonic anhydrase IX (CA IX) tumor antigen
US7378091B2 · kind B2 · utility
20Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2002 |
| Grant date | May 27, 2008 |
| Priority date | — |
| Expiry date | Apr 12, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to the generation and characterization of anti-CA IX monoclonal antibodies. The invention further relates to the use of such anti-CA IX antibodies in the diagnosis and treatment of disorders associated with increased activity of CA IX, in particular, tumors such as colorectal cancer, renal cell carcinoma (RCC), cervical and other cancers of epithelial origin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.